2020 Volume 50 Issue 3 Pages 101-107
Background: It is not still definitive if serum triglycerides are residual cardiovascular risk.
Objectives: We aimed to summarize the clinical relevance of targeting serum triglycerides to reduce residual cardiovascular risk based on genetic studies and clinical studies.
Methods: We have summarized large scale genetic studies as well as clinical studies focusing on our objective.
Results: Serum triglycerides appeared to be associated with residual cardiovascular events.
Conclusion: Triglycerides should be targeted to reduce residual cardiovascular risk.